Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e14df5c297ab0465c3d9ef25b667e990 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a056028050ba7dd8126057a1f425630a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8279f16bdfa9a8944aef3d330f8d523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84bae1e2d3c3a33be047241742fdfeb8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-545 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
filingDate |
1997-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c01a88a8070843565e624fa6bb22c83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fc4a7c0ca0e4b2aa9905653bad900d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a231cde27115b308b78b7e78d5fc539f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c697ebac095626ff92165862a3e2333 |
publicationDate |
1999-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0920254-A1 |
titleOfInvention |
Programmed cell death and ich-3 |
abstract |
This invention relates to modulation of programmed cell death. It also relates to transgenic non-human animals comprising a disrupted Ich-3 gene and methods of making these animals. The Ich-3 mutant animals exhibit resistance to septic shock and defects in folliculogenesis. This invention also relates to methods of using the transgenic animals to screen for compounds to treat septic shock and defective folliculogenesis. Moreover, this invention also relates to methods of treating septic shock in normal individuals by inhibiting ICH-3. |
priorityDate |
1996-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |